Vaccine Development

Clinical Trials mRNA Technology Regulatory Approval COVID-19 Vaccines mRNA Vaccines Safety and Efficacy Research Funding Emergency Use Authorization Vaccine Research Vaccine Safety Advisory Committees Vaccine Supply Pharmaceutical Companies Regulatory Agencies Covid-19 Vaccines RNA Technology Immunization Programs Public Health COVID-19 Biotechnology Vaccine Production Manufacturing Capacity Chikungunya Virus FDA Regulations Immunology Vaccine Effectiveness Immunization Regulatory Bodies Vaccine Hubs

AI Pinpoints Single-Protein Mpox Target That Elicits Neutralizing Antibodies in Mice

AlphaFold 3 guidance focuses countermeasure design on OPG153 to enable simpler manufacturing than whole‑virus shots.

Florida Starts Process to Drop Four School Vaccine Requirements

HHS Withdraws $766 Million for Moderna’s Bird Flu mRNA Vaccine